Last reviewed · How we verify
Vehicle Cream
Vehicle Cream is an inert topical formulation base used as a delivery system for active pharmaceutical ingredients in dermatological applications.
Vehicle Cream is an inert topical formulation base used as a delivery system for active pharmaceutical ingredients in dermatological applications. Used for Pharmaceutical vehicle/excipient for topical dermatological formulations.
At a glance
| Generic name | Vehicle Cream |
|---|---|
| Also known as | Placebo, Placeco, Vehicle, HSA, Human Serum Albumin |
| Sponsor | Organon and Co |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
Vehicle Cream serves as a pharmaceutical excipient and delivery platform rather than an active drug itself. It is designed to provide an appropriate medium for topical application, ensuring proper absorption, stability, and patient tolerability of active ingredients when incorporated into the formulation.
Approved indications
- Pharmaceutical vehicle/excipient for topical dermatological formulations
Common side effects
Key clinical trials
- Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial) (PHASE2)
- Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa (PHASE3)
- Topical Ketotifen 0.25% for Secondary Vestibulodynia (PHASE2)
- A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis (PHASE2)
- A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis (PHASE3)
- Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2) (PHASE3)
- Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1) (PHASE3)
- Topical Anti-Androgens in Pilonidal Sinus Disease (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vehicle Cream CI brief — competitive landscape report
- Vehicle Cream updates RSS · CI watch RSS
- Organon and Co portfolio CI